Suchergebnisse - "Sebastian, Shaji"

PubPharm (12)

1

Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients

enthalten in: Journal of Crohn's & colitis | 2024

von Bai, B. | Reppell, M. | Smaoui, N. | +111

2

Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease

enthalten in: Biomolecules | 2023

von Hanić, M. | Vučković, F. | Deriš, H. | +108

3

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD) : an analysis of a prospective multicentre cohort study

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Liu, Z. | Le, K. | Zhou, X. | +120

CommentIn: Lancet Gastroenterol Hepatol. 2023 Feb;8(2):99-100. - PMID 36481042

4

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

enthalten in: EBioMedicine | 2023

von Alexander, J. | Mullish, B. | Danckert, N. | +24

5

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP) : a multicentre, prospective, case-control study

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Alexander, J. | Liu, Z. | Muñoz Sandoval, D. | +67

6

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease : results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Chanchlani, N. | Lin, S. | Auth, M. | +99

CommentIn: Aliment Pharmacol Ther. 2022 Oct;56(8):1294-1295. - PMID 36168263

7

Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease : Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Pauwels, R. | van der Woude, C. | Nieboer, D. | +55

CommentIn: Clin Gastroenterol Hepatol. 2022 Aug;20(8):1668-1670. - PMID 34058414

8

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

enthalten in: Nature communications | 2022

von Lin, S. | Kennedy, N. | Saifuddin, A. | +130

9

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses : Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

enthalten in: Journal of Crohn's & colitis | 2022

von Chanchlani, N. | Lin, S. | Chee, D. | +22

10

Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease : An ECCO CONFER Case Series

enthalten in: Journal of Crohn's & colitis | 2022

von Phillips, F. | Verstockt, B. | Ribaldone, D. | +15

ErratumIn: J Crohns Colitis. 2022 Nov 1;16(10):1648. - PMID 35751543